Education
About Us
Working with TipRanks
Follow Us
Avita Medical (RCEL)
NASDAQ:RCEL
Earnings Data
Report Date
Nov 06, 2025Before Open (Confirmed)
Period Ending
2025 (Q3)Consensus EPS Forecast
-0.26Last Year’s EPS
-0.62Same Quarter Last Year
Moderate Buy
Based on 5 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The earnings call highlighted significant achievements, including a 21% increase in commercial revenue and major clinical evidence supporting RECELL's effectiveness. Key challenges were noted in reimbursement delays impacting revenue and a lowered financial forecast. Despite the challenges, the company is optimistic about a recovery in the second half of the year and has implemented cost-saving measures.Company Guidance
Increase in Commercial Revenue
Commercial revenue for the second quarter was $18.4 million, up 21% year-over-year.
Major Clinical Evidence
A real-world analysis of the U.S. National Burn Registry showed that RECELL reduced the length of stay by 36% for patients with deep second-degree burns.
Outcomes-Based Partnership Agreements
Two major hospitals are adopting broader RECELL eligibility protocols, potentially increasing their RECELL units by approximately 150 additional patients each month.
NTAP Approval for RECELL
Received CMS approval for a special reimbursement called NTAP, which is designed to accelerate access to breakthrough devices like RECELL.
Successful Cohealyx Launch
Cohealyx saw significant growth, with the largest account ordering nearly $300,000 of Cohealyx in July alone.
Reduction in Operating Expenses
Operating expenses for the quarter were $26.1 million, down from $28.7 million in the same period of 2024, due to a $2.5 million per quarter reduction in sales and marketing costs.
RCEL Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
RCEL Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Aug 07, 2025 | $5.38 | $4.25 | -21.00% |
May 08, 2025 | $9.33 | $6.97 | -25.29% |
Feb 13, 2025 | $8.78 | $10.57 | +20.39% |
Nov 07, 2024 | $12.40 | $11.95 | -3.63% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Avita Medical (RCEL) report earnings?
Avita Medical (RCEL) is schdueled to report earning on Nov 06, 2025, Before Open (Confirmed).
What is Avita Medical (RCEL) earnings time?
Avita Medical (RCEL) earnings time is at Nov 06, 2025, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is RCEL EPS forecast?
RCEL EPS forecast for the fiscal quarter 2025 (Q3) is -0.26.